We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 10.10 | 9.70 | 10.50 | 10.10 | 9.975 | 10.10 | 211,828 | 08:00:21 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.83 | 93.71M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/10/2017 10:05 | Thanks Goosed. I'm not sure that they've seen these links on LSE - if you have time, why not post them over there too ? Nice one. | torquayfan | |
30/10/2017 09:47 | May be of interest to some : | gooosed | |
30/10/2017 09:24 | While waiting for news (hopefully significant) in November - this clip underlines the return of vaccines : "Studies at MD Anderson are primarily vaccine trials as well as a few looking at checkpoint blockade" Could Moditope be a candidate for inclusion (in time) together with SCIB1 at MD Anderson. Roll on 8 Nov | gooosed | |
27/10/2017 17:42 | "Yeah even Wigwammer's keeping his trap shut about his entry point"I only come here when I'm extremely bored.The frequency and longevity of your presence says a lot. | wigwammer | |
27/10/2017 01:12 | TF, and i answered it. I said"" I understand fully criticism of RG."", I did not say i shared that criticism. I actually gave a list of news which we would expect to occur in his time left as CEO, which will leave most of us feeling RG has done a very good job. He has steered us through 17 years of service too, just to get us to this place, really hope he does leave his role with the tools which will allow Dr Holloway to hit the ground running. | chelsea35 | |
26/10/2017 23:46 | Wanderer - it's arguable whether two platforms with patent protection and 6 target indications so far, represents 'zilch' as you say. The breadth, depth and complexity of Scancell's 'on the edge' science is a massive project for a small team. I hope you will be 'eating your words' about RG before too long ? C7 it's not sweet - just my 'measured' take. You've seen GF's comment on your 'position' on RG, in the other place ? We are all aware of what 'could occur' before Dr Chris Holloway joins the Scancell team - btw he is not taking the 'Chair' - that remains JC's I believe. And RG will still be around - that's excellent IMO because RG will have myriad insights into the personalities and corporates on the 'scene' and he will be a great help to the new CEO. GLA | torquayfan | |
26/10/2017 18:25 | But it is not only us. Just take a look at IMMs share price five years ago, only a few months ago hitting a low of 20p, whilst IN a Phase 3 trial. Just touching that magic £1 mark now and looking very strong. There was never really much doubt about succeeding in that trial. So from 20p-£1 in months and they were fully funded during that period. I understand fully criticism of RG. Been a long time since inflection news only to rise on an FT share tip and positive feedback from the AGM, only to drift back with no further momentum news. We can only hope for decent funding news, IND Approval and confirmation of patient recruitment for SCIB1 Combo Trial............... TF, you"re baiting of those who are not RGs best fans is very sweet, I prefer to make a case for what could occur before the new CEO takes the chair. | chelsea35 | |
26/10/2017 17:11 | Lol TF, of course it's AIM, that's how the CEO as got away with "baiting" the market for many years and delivering Zilch, only on AIM would this happen lol | wanderer1210_0 | |
26/10/2017 16:41 | Yes I am thank you | gazza | |
26/10/2017 15:35 | Gash - I hope / trust, you are fully recovered ??? | the real lozan | |
26/10/2017 14:47 | Tosh you really do see things in the worst of all possible lights whenever you think you can get away with it - I'm not suggesting there is any insight, reason or strategy in your 'approach'. I listened again to the AGM recording and for me there was much to be reassured about. The sentiment is not negative - it's the AIM market. Great post from Steve 67 on LSE and I apologise to him for quoting ''7k GBP of sales and we lose 1M GBP MCAP! At this rate, if someone sells 243k GBP we'd have an share price & MCAP of 0!'' Tosh the volumes of sales are tiny. Sentiment is fine M8 - AIM ain't. Of course we wait eagerly for news of the Moditope Patent and a deal at some stage. Patience - I say to myself. | torquayfan | |
26/10/2017 14:46 | Well it is your club house Lozan, indeed a very familiar odour. | chelsea35 | |
26/10/2017 14:38 | Thanks for that loz, your weather reports are the highlight of my day. Atb | gazza | |
26/10/2017 11:22 | Do *WE* detect a familiar odour eminating from the CLUB house ??? Maybe, I was being 'generous' when I mentioned the number 11 Good to see however, that certain Alternative Views- do not fall only on 'deaf-ears' . Meanwhile - for the info of Gash = Clear blue skies, 33 C in the sun | the real lozan | |
26/10/2017 11:04 | Yeah even Wigwammer's keeping his trap shut about his entry point, ( not a bad thing) | wanderer1210_0 | |
26/10/2017 10:23 | It looks like the realisation that someone has to deliver a deal or the share price will dwindle back down to single figures, is starting to manifest itself. Earlier than i thought if im honest, but the pressure on the share price is already evident. Come on guys, lets have something... anything to redress the obvious negative sentiment. | tosh123 | |
23/10/2017 14:53 | hxxp://www.fiercepha | bermudashorts | |
23/10/2017 10:05 | CLUBs are TRUMPS - As the REALITY of the AGM begins to 'sink-in', the 'euphoria' that was 'pushed' by the BUY, BUY, BUY gang appears to have 'run-out-of-steam'.. With circa 11 weeks for SCLP to come-up-with the FUNDING, the CLUBS insisted = the 'new man' would undoubtedly have 'to play with' ... BEFORE he takes over = 'Jam Tomorrow'.... NO ONE is mentioning that the VITAL FUNDING is ONLY the START That VITAL FUNDING is the 'basic requirement', in order to FUND / ALLOW those Trials, which are CRUCIAL to allow SCLP to progress- to BEGIN. . NO ONE seems to want to draw attention to REALITY in the 'CLUBs are tRAMPS' crew. Nor do *WE* see much on the topic of exactly what that VITAL FUNDING might / will cost, by way of dilution / S P etc, etc. . *WE* might remind ourselves that the *Knave of tRAMPS* ... repeatedly made the FALSE CLAIM... 7 months ago,that this would be "£6 a share, in 18 months" By January, that will be "£6 a share" in 8 months ??? { Even IF the VITAL FUNDING to BEGIN those VITAL TRIALS is in place by January } . Does this "£6 a share' in 8 or 11 months SOUND any more REALISTIC now... or Does "£6 a share" in now 11 months, SOUND as UN-REALISTIC now , as it did for some... when that FALSE CLAIM was made ??? . *WE* may see more of that number 11 | the real lozan | |
23/10/2017 04:53 | INV that's just a cheap shot at RG. Never mind - you're good at something ! Terror - well at least you admit to being 50% a Buffoon - fair enough. ATB | torquayfan | |
23/10/2017 03:05 | RG spent his whole career failing in everything he did | inv | |
22/10/2017 23:02 | TorquayFan - No, it says more about RG than me. I am only half a Buffoon. I guess you need therapy. | terror | |
21/10/2017 11:46 | Hello Terror. It seems to me over the years that Prof. Lindy has had an excellent relationship with RG and I'd guess she holds RG in the highest regard. No indication otherwise certainly. As for the 'B' word - that's a bit strong to say the least. But it's easy to make cheap shots on the internet and maybe it tells us more about you than RG. Nice weekend to you. | torquayfan | |
20/10/2017 14:39 | You can do nothing without the funding to develop it through clinical trials. I feel sorry for Lindy being saddled with a buffoon called Goodfellow, an OXYMORON indeed. | terror | |
19/10/2017 15:09 | What was it Prof. Durrant said about Moditope, turning Cold tumours Hot . . . . ? Anyway - seems others are beginning to catch up on her thinking | gooosed | |
19/10/2017 13:17 | In November Scancell are attending : PEGS - & Health EX World Forum - but also November sees the publication of Moditope related news - via the EPO which fingers crossed should see news of some consequence. Scope then perhaps for an announcement or two in the not too distant future. | gooosed |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions